Pathogenic human monoclonal antibody against desmoglein 3

Clinical Immunology

Volumn 120, Issue 1, 2006, Pages 68-75

  Yeh, Shih Wei ^a   Cavacini, Lisa A ^b   Bhol, Kailash C ^a   Lin, Mong Shang ^c   Kumar, Mukesh ^b   Duval, Mark ^b   Posner, Marshall R ^b   Ahmed, A Razzaque ^a,d  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

Autoantibody; Pathogenesis; Pemphigus vulgaris

Indexed keywords

CELL SURFACE PROTEIN; DESMOGLEIN 1; DESMOGLEIN 3; HUMAN MONOCLONAL ANTIBODY; HUMAN MONOCLONAL ANTIBODY PVMAB786; IMMUNOGLOBULIN G4; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; DSG3 PROTEIN, HUMAN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ACANTHOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; EPITHELIUM CELL; GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION; KERATINOCYTE; MOUSE; MUCOSA; NEWBORN; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOGENICITY; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SKIN; ANIMAL; BAGG ALBINO MOUSE; EPITOPE MAPPING; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOTHERAPY; INTRACUTANEOUS TEST; METHODOLOGY; PEMPHIGUS; WESTERN BLOTTING;

ACANTHOLYSIS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; DESMOGLEIN 3; EPITOPE MAPPING; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTRADERMAL TESTS; KERATINOCYTES; MICE; MICE, INBRED BALB C; PEMPHIGUS;

EID: 33746709482     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.03.006     Document Type: Article

References (32)

1. Ahmed A.R. Lymphocyte studies in pemphigus. Arch. Dermatol. Res. 271 (1981) 111-115
2. Simon D.G., Krutchkoff D., Kaslow R.A., and Zarbo R. Pemphigus in Hartford County, Connecticut, from 1972-1977. Arch. Dermatol. 116 (1980) 1035-1037
3. Anhalt G., Labib R., Voorhees J., Beals T., and Diaz L. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306 (1982) 1189-1196
4. Parlowsky T., Welzel J., Amagai M., Zillikens D., and Wygold T. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns. J. Am. Acad. Dermatol. 48 (2003) 623-625
5. Ahmed A.R., Mohimen A., Yunis E.J., Mirza N.M., Kumar V., Beutner E.H., and Alpher C.A. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J. Exp. Med. 177 (1993) 419-424
6. Bhol K., Natarajan K., Nagarwalla N., Mohimen A., Aoki V., and Ahmed A. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc. Natl. Acad. Sci. 92 (1995) 5239-5243
7. Gilbert D., Joly P., Jouen F., Thibout A., Delpech A., Thomine E., Lauret P., and Tron F. Production of a human monoclonal anti-epithelial cell surface antibody derived from a patient with pemphigus vulgaris. J. Autoimmun. 5 (1992) 173-182
8. Fan J.-L., Memar O., McCormick D.J., and Prabhakar B.S. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3. J. Immunol. 163 (1999) 6228-6235
9. Bhol K.C., and Ahmed A.R. Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient. Autoimmunity 35 (2002) 87-91
10. Payne A.S., Ishii K., Kacir S., Lin c., Li H., Hanakawa Y., Tsunoda K., Amagai M., Stanley J.R., and Siegel D.L. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J. Clin. Invest. 115 (2005) 888-899
11. Miller G., and Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. 70 (1973) 190-194
12. Posner M., Elboim H., and Tumber M. The regulation of Epstein Barr Virus transformation of B cells secreting cell surface reactive antibodies. Autoimmunity 8 (1990) 141-158
13. Posner M., Elboim H., and Santos D. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 6 (1987) 611-625
14. Liu F., Bergami P.L., Duval M., D D.K., Posner M., and Cavacini L. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Res. Hum. Retroviruses 19 (2003) 597-607
15. Sabolinski L., Beutner E.H., Krasny V., Kumar V., Huang J., Chorzelski T.P., Sampaio S., and Bystryn J.D. Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections. J. Invest. Dermatol. 88 (1987) 545-549
16. Bhol K., Tyagi S., Natarajan K., Nagarwalla N., and Ahmed A.R. Use of recombinant pemphigus vulgaris antigen in development of ELISA and Ib assays to detect pemphigus vulgaris autoantibodies. J. Eur. Acad. Dermatol. Venereol. 10 (1998) 28-35
17. Mohimen A., and Ahmed A.R. Immunoblot assay to study the pemphigus vulgaris antigen in normal human epidermis and COLO-16 cell line. Arch. Dermatol. Res. 285 (1993) 165-167
18. Ding X., Aoki V., Mascaro Jr. J.M., Lopez-Swiderski A., Diaz L.A., and Fairley J.A. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J. Invest. Dermatol. 109 (1997) 592-596
19. Arteaga L.A., Prisayanh P.S., Warren S.J., Liu Z., Diaz L.A., and Lin M.S. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against desmoglein-1 and desmoglein-3. J. Invest. Dermatol. 118 (2002) 806-811
20. Ahmed A.R., Wagner R., Khatri K., Notani G., Awdeh Z., Alper C.A., and Yunis E.J. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. 88 (1991) 5056-5068
21. Ahmed A.R., Yunis E.J., Khatri K., Wagner R., Notani G., Awdeh Z., and Alper C.A. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc. Natl. Acad. Sci. 87 (1990) 7658-7662
22. Colon J., Bhol K., Razzaque M., and Ahmed A. In vitro organ culture model for mucous membrane pemphigoid. Clin. Immunol. 98 (2001) 229-234
23. Kumari S., Bhol K.C., Simmons R.K., Razzaque M.S., Letko E., Foster C.S., and Ahmed A.R. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin. Invest. Opthamol. Visual Sci. 42 (2001) 379-385
24. Weitkamp J.H., Kallewaard N.L., Bowen A.L., Lafleur B.J., Greenberg H.B., and Crowe J.E. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J. Immunol. 174 (2005) 3454-3460
25. Amagai M., Komai A., Hashimoto t., Shirakata Y., Hashimoto K., Yamada T., Kitajima Y., Ohya K., Iwanami H., and Nishikawa T. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br. J. Dermatol. 140 (1999) 351-357
26. Cheng S.W., Kobayashi M., Kinoshita-Kuroda K., Tanikawa A., Amagai M., and Nishikawa T. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br. J. Dermatol. 147 (2002) 261-265
27. Ishii K., Amagai M., Hall R., Hashimoto T., Takayanagi A., Gamou S., Shimizu N., and Nishikawa T. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159 (1997) 2010-2017
28. Sams W., and Jordan R. Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br. J. Dermatol. 84 (1971) 7-13
29. Aoki-Ota M., Tsunoda K., Ota T., Iwasaki T., Koyasu S., Amagai M., and Nishikawa T. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Br. J. Dermatol. 151 (2004) 346-354
30. Amagai M., Koch P.J., Nishikawa T., and Stanley J.R. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106 (1996) 351-355
31. Herrmann G., Engert A., and Hunzelmann N. Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab). Br. J. Dermatol. 148 (2003)
32. Morrison L.H. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J. Am. Acad. Dermatol. 51 (2004) 817-819